Integrated DNA Technologies

Integrated DNA Technologies, Inc. specializes in the development, manufacturing, and supply of custom oligonucleotides for the life sciences sector, particularly in research and diagnostics. The company focuses on producing synthetic nucleic acids for various molecular biology applications, including qPCR, sequencing, and synthetic biology. Its offerings encompass a range of products and services such as DNA and RNA synthesis, gene silencing technologies, and next-generation sequencing tools. These products support research in genetic diseases, infectious diseases, drug discovery, and agricultural applications. Integrated DNA Technologies employs advanced synthesis and purification technologies to ensure high-quality products, allowing researchers to utilize custom-made oligonucleotides effectively. The company serves a diverse clientele, from small academic laboratories to large pharmaceutical firms, and has a global presence with facilities in multiple countries. Founded in 1987 and headquartered in Coralville, Iowa, it operates as a subsidiary of Danaher Corporation.

Joseph Walder

Founder

4 past transactions

ArcherDX

Acquisition in 2022
ArcherDX, Inc. is a genomics company headquartered in Boulder, Colorado, specializing in the development and commercialization of advanced genetic analysis products. Established in 2013, the company focuses on next-generation sequencing technologies to enhance genetic mutation detection, particularly in oncology. ArcherDX offers a range of research-use-only products, including DNA-based VariantPlex, RNA-based FusionPlex, and ctDNA-based LiquidPlex assays. These products enable laboratories to conduct genomic analyses for therapy optimization and cancer monitoring. Additionally, ArcherDX provides customized assay design services for clinical and biopharmaceutical clients, allowing them to target specific biomarkers and develop new applications. The company aims to deliver actionable genomic information for the treatment of solid tumors, blood cancers, and sarcomas, catering to academic laboratories, biopharmaceutical firms, and contract research organizations. ArcherDX also seeks regulatory approval for various companion diagnostic assays to further support precision medicine initiatives.

Swift Biosciences

Acquisition in 2021
Swift Biosciences Inc. is a biotechnology company based in Ann Arbor, Michigan, specializing in the development and commercialization of next-generation sequencing (NGS) library preparation kits for genomics and clinical research. The company offers a comprehensive range of products, including RNA library kits, amplicon panels, hybridization capture kits, and specialized kits for cancer gene profiling and COVID-19 testing. Swift Biosciences aims to streamline NGS sample preparation processes through innovative reagents and protocols, enhancing the usability of data obtained from sequencing instruments. Its offerings cater to various applications such as whole-genome sequencing, metagenomics, and the analysis of circulating tumor cells. The company operates through a network of distributors across the Asia Pacific, Europe, the Middle East, and South America, and was incorporated in 2009.

GeneWorks

Acquisition in 2017
GeneWorks specializes in providing molecular and cell biology products and services tailored to the research community. The company distributes a range of instruments, kits, reagents, and software designed to support various applications, including protein biomarker discovery, genetic analysis, and immunology. Their offerings encompass spatial biology, biomarker validation, rapid test kits, and genotyping products, facilitating assay design, validation, and execution for researchers and organizations. Through its comprehensive portfolio, GeneWorks aims to assist in advancing scientific research and innovation.

ValueGene

Acquisition in 2016
ValueGene Inc. is a biotech service company based in San Diego, California, specializing in gene discovery services. Founded in 2005, the company offers custom DNA synthesis and RNA oligonucleotide synthesis services tailored for biological research laboratories, including those at academic institutions and biotech firms. As of June 2016, ValueGene operates as a subsidiary of Integrated DNA Technologies, Inc.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.